Ghent, Belgium

Hans Wim Pieter Vermeersch


 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Hans Wim Pieter Vermeersch

Introduction

Hans Wim Pieter Vermeersch is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HIV protease inhibitors. With a total of four patents to his name, Vermeersch has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

Vermeersch's latest patents include the disclosure of new pseudopolymorphic forms of a HIV protease inhibitor. These forms are specifically related to (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate. The processes for producing these compounds are also detailed in his patents, showcasing his expertise in pharmaceutical chemistry.

Career Highlights

Throughout his career, Vermeersch has worked with prominent companies in the pharmaceutical industry. He has been associated with Tibotec Pharmaceuticals Ltd. and Janssen R&D Ireland, where he has contributed to various research and development projects. His work has had a lasting impact on the field, particularly in the fight against HIV.

Collaborations

Vermeersch has collaborated with several notable professionals in his field. Among his coworkers are Daniel Joseph Christiaan Thone and Luc Donne Marie-Louise Janssens, who have also made significant contributions to pharmaceutical research.

Conclusion

Hans Wim Pieter Vermeersch is a distinguished inventor whose work in the development of HIV protease inhibitors has advanced medical science. His patents and collaborations reflect his dedication to innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…